Thomas S. Mchugh

Insider Reports History

Location
2280 Schuetz Road, St. Louis, MO
Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas S. Mchugh:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AVADEL PHARMACEUTICALS PLC Chief Financial Officer Ordinary Shares 100K $796K $7.93 Mar 5, 2025 Direct
AVADEL PHARMACEUTICALS PLC Chief Financial Officer Stock Option (Right to Buy) 72K Mar 5, 2025 Direct

Insider Reports Filed by Thomas S. Mchugh

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVDL AVADEL PHARMACEUTICALS PLC Mar 5, 2025 2 $0 4 Mar 7, 2025 Chief Financial Officer
AVDL AVADEL PHARMACEUTICALS PLC Dec 13, 2024 1 $24K 4 Dec 16, 2024 Chief Financial Officer
AVDL AVADEL PHARMACEUTICALS PLC Dec 11, 2024 1 $52.4K 4 Dec 12, 2024 Chief Financial Officer
AVDL AVADEL PHARMACEUTICALS PLC Feb 20, 2024 1 $0 4 Mar 4, 2024 Chief Financial Officer
AVDL AVADEL PHARMACEUTICALS PLC Jan 16, 2024 1 $29K 4 Jan 16, 2024 Chief Financial Officer
AVDL AVADEL PHARMACEUTICALS PLC Aug 14, 2023 1 $28.9K 4 Aug 14, 2023 Chief Financial Officer
AVDL AVADEL PHARMACEUTICALS PLC Jun 5, 2023 1 $0 4 Jun 5, 2023 Chief Financial Officer
AVDL AVADEL PHARMACEUTICALS PLC Nov 29, 2022 1 $39K 4 Nov 30, 2022 Chief Financial Officer
AVDL AVADEL PHARMACEUTICALS PLC May 27, 2022 1 $107K 4 May 31, 2022 Chief Financial Officer
AVDL AVADEL PHARMACEUTICALS PLC Dec 7, 2021 1 $0 4 Dec 9, 2021 Chief Financial Officer